Contents Interim report
Overview 4
Analysis of results 4
Operating capital generation 6
Sales and value of new business 7
Earnings per ordinary share 39
Segments 41
Taxation 46
Fair value of financial assets and liabilities 46
Companies and businesses acquired and divested 49
Conformity statement Conformity statement | 9 | Authorisation of the Condensed consolidated 51 interim accounts | |
Condensed consolidated interim accoun | ts | Other information | 53 |
Condensed consolidated balance sheet | 11 | Contact and legal information | 55 |
Condensed consolidated profit and loss account | 12 | ||
Condensed consolidated statement of comprehensive income Condensed consolidated statement of cash flows | 13 14 | ||
Consolidated statement of changes in equity | 16 | ||
Accounting policies | 18 | ||
Investments at fair value through Other Comprehensive Income Investments at cost | 18 19 | ||
Investments at fair value through profit or loss | 20 | ||
Investments in associates and joint ventures | 21 | ||
Intangible assets | 22 | ||
Other assets | 22 | ||
Equity | 22 | ||
Insurance contracts | 24 | ||
Subordinated debt | 36 | ||
Derivatives | 36 | ||
Other liabilities | 36 | ||
Insurance income | 37 | ||
Insurance expenses | 37 | ||
Investment result | 38 | ||
Finance result | 39 | ||
Non-attributable operating expenses | 39 | ||
Capital and liquidity management 50
Independent auditor's review report
Interim reportOverview
OverviewNN Group is an international financial services company, active in 10 countries, with a strong presence in a number of European countries and Japan. With all its employees, the Group provides retirement services,
1 January to
Basic earnings per ordinary share in EUR | 3.93 | 1.31 |
30 June 2026
1 January to
30 June 2025
pensions, insurance, banking and investments to approximately 18 million customers. NN Group includes Nationale-Nederlanden, NN, ABN AMRO Insurance, Movir, AZL, BeFrank and OHRA. NN Group is listed on Euronext Amsterdam (NN).
Analysis of resultsOperating result and net result
1 Operating result is an Alternative Performance Measure. This measure is derived from figures according to IFRS-EU. The operating result is derived by adjusting the reported result before tax to exclude the impact of result on divestments, amortisation of acquisition intangibles, discontinued operations and special items, changes to losses from onerous contracts due to assumption changes, gains/losses and impairments, revaluations and market and other impacts. Alternative Performance Measures are non-IFRS-EU measures that have a relevant IFRS-EU equivalent. For definitions and explanations of the Alternative Performance Measures reference is made to Note 19 'Segments' in section 'Alternative Performance Measures (Non-GAAP measures)'.
Netherlands Life | 801 | 829 |
Netherlands Non-life | 249 | 231 |
Insurance Europe | 345 | 277 |
Japan Life | 80 | 82 |
Banking | 77 | 76 |
Other | -46 | -51 |
Operating result1 | 1,507 | 1,443 |
Non-operating items | -97 | -678 |
- of which gains/losses and impairments | -294 | -238 |
- of which revaluations | 269 | -429 |
- of which market and other impacts | -72 | -11 |
Special items | -45 | -91 |
Acquisition intangibles and goodwill | -14 | -14 |
Result on divestments | -131 | |
Result before tax | 1,351 | 528 |
Taxation | 277 | 132 |
Minority interests | 8 | 5 |
Net result | 1,066 | 391 |
In EUR million
1 January to
30 June 2026
1 January to
30 June 2025
Operating result
The operating result of NN Group increased 4% to EUR 1,507 million.
Netherlands Life's operating result decreased to EUR 801 million from EUR 829 million in 1H25, mainly due to lower investment results reflecting lower private investment results and a lower public equity portfolio.
Netherlands Non-life's operating result increased to EUR 249 million from EUR 231 million in the first half of 2025. The combined ratio for the first half year was 90.5%, ahead of the 91-93% guidance range, compared with 91.2% in the same period last year, driven by favourable claims experience despite adverse weather
in June.
The operating result of Insurance Europe increased to EUR 345 million from EUR 277 million in the first half of 2025, largely from continued strong business growth and favourable claims experience.
Japan Life's operating result decreased slightly to EUR 80 million, as adverse exchange rates and the run-off of the short-term portfolio were partly offset by a more favourable mortality result.
The operating result for Banking was broadly stable at EUR 77 million.
The operating result of the segment Other was EUR -46 million compared with EUR -51 million in the first half of 2025.
Result before tax
The result before tax increased to EUR 1,351 million from EUR 528 million in the first half of 2025, due to positive revaluations and the higher operating result for the current half-year, the negative divestment result in 1H25, as well as lower costs related to the 'Future Ready' strategic programme.
Gains/losses and impairments were EUR -294 million compared with EUR -238 million in the first half of 2025, primarily reflecting accounting losses on government bond sales.
Revaluations amounted to EUR 269 million compared with EUR -429 million in the first half of 2025, mainly due to positive revaluations on real estate and private equity, partly offset by derivatives used for hedging purposes.
Market and other impacts amounted to EUR -72 million compared with EUR -11 million in the first half of 2025.
Special items amounted to EUR -45 million compared with EUR -91 million in the same period last year, mainly reflecting costs related to the 'Future Ready' strategic programme partly offset by a provision release.
Net result
The net result increased to EUR 1,066 million compared with EUR 391 million in the first half of 2025. The effective tax rate was 20.5%.
Operating capital generation
Operating capital generationOperating capital generation per segment
Netherlands Life | 605 | 595 |
Netherlands Non-life | 168 | 175 |
Insurance Europe | 299 | 251 |
Japan Life | 61 | 59 |
Banking | 65 | 66 |
Other | -126 | -126 |
Operating capital generation1 | 1,073 | 1,020 |
In EUR million
1 January to
30 June 2026
1 January to
30 June 2025
Japan Life's OCG grew 4% to EUR 61 million, as benefits from higher interest rates and the move to Solvency II from the second quarter of 2026 more than offset portfolio effects and adverse exchange rates.
As of this reporting period, Banking OCG is based on remittances to the Group following the exclusion of NN Bank from the NN Group Solvency II ratio, amounting to EUR 65 million in the first half of 2026.
OCG of the Other segment was broadly in line with the first half of 2025.
1 Operating capital generation is an Alternative Performance Measure, which is not derived from IFRS-EU. NN Group analyses the change in the excess of Solvency II Own Funds over the Solvency Capital Requirement (SCR) in the following components: Operating Capital Generation, Market variance, Capital flows and Other. Operating capital generation is the movement in the solvency surplus (Own Funds before eligibility constraints over SCR at 100%) in the period due to operating items, including the impact of new business, expected investment returns in excess of the unwind of liabilities, release of the risk margin, operating variances, non-life underwriting result, contribution of non-Solvency II entities and holding expenses and debt costs and the change in the SCR. It excludes economic variances, economic assumption changes and non-operating expenses. For definitions and explanations of the Alternative Performance Measures reference is made to the Note 19 'Segments' in section 'Alternative Performance Measures (Non-GAAP measures)'.
NN Group's OCG increased 5% to EUR 1,073 million, driven by business growth at Insurance Europe.
Insurance Europe reported 19% higher OCG, supported by new business growth and higher pension fees from increased assets under management and performance fees. Growth was mainly driven by Romania, Poland and Slovakia, while Greece also contributed through strong bancassurance sales, although these are expected to soften significantly in 2027.
Netherlands Non-life's OCG decreased by 4% to EUR 168 million compared with the first half of 2025, as adverse weather, higher claims in Group Income and lower broker results were partly offset by growth in the P&C portfolio and margin improvements in Motor.
Netherlands Life's OCG increased by 2% to EUR 605 million, mainly reflecting a higher SCR release partially offset by a lower positive experience variance.
Sales and value of new business
Sales and value of new businessSales and value of new business
In EUR million
1 January to
30 June 2026
1 January to
30 June 2025
Gross premiums written | 7,449 | 7,462 |
New sales life insurance (APE) | 917 | 750 |
Value of new business | 275 | 237 |
Assets under management DC
30 June 2026
31 December
2025
Assets under management DC (in EUR billion) | 48.2 | 42.6 |
New sales life insurance (APE) increased 22%, mainly reflecting the transfer of a separate account pension fund to the general account at Netherlands Life.
Insurance Europe reported strong new sales around the region, resulting in 10% APE growth.
Japan Life saw demand shift towards shorter-duration products, slowing the recovery in sales. APE declined 22%, or 11% on a constant currency basis.
Gross written premiums for Netherlands Non-life increased 6%. VNB increased 16% to EUR 275 million in the first half of 2026. Netherlands Life VNB growth was largely driven by a pension fund transaction. VNB of
Insurance Europe increased 14% from higher sales and a favourable product mix. VNB in Japan declined 16%, or 5% on a constant-currency basis, mainly due to lower volumes, partly offset by higher interest rates.
Assets under management of the defined contribution pension business grew to EUR 48.2 billion, with EUR 1.7 billion net inflows and EUR 3.9 billion market impacts in the first half of 2026.
Conformity statementConformity statement
Conformity statementThe Executive Board of NN Group N.V. is required to prepare the Interim report and Condensed consolidated interim accounts of NN Group N.V. in accordance with applicable Dutch law and International Financial Reporting Standards that are endorsed by the European Union (IFRS-EU).
Conformity statement pursuant to section 5:25d paragraph 2(c) of the Dutch Financial Supervision Act (Wet op het financieel toezicht)
The Executive Board of NN Group N.V. is responsible for maintaining proper accounting records, for safeguarding assets and for taking reasonable steps to prevent and detect fraud and other irregularities.
It is responsible for selecting suitable accounting policies and applying them on a consistent basis, making judgements and estimates that are prudent and reasonable. It is also responsible for establishing and maintaining internal procedures which ensure that all major financial information is known to the Executive Board of NN Group N.V., so that the timeliness, completeness and correctness of the external financial reporting are ensured. As required by section 5:25d paragraph 2(c) of the Dutch Financial Supervision Act,
each of the signatories hereby confirms that to the best of his knowledge:
The NN Group N.V. Condensed consolidated interim accounts for the period ended 30 June 2026 give a true and fair view of the assets, liabilities, financial position and profit or loss of NN Group N.V. and the
enterprises included in the consolidation taken as a whole.
The NN Group N.V. Interim report for the period ended 30 June 2026 includes a fair review of the information required pursuant to article 5.25d, paragraph 8 and 9 of the Dutch Financial Supervision Act
regarding NN Group N.V. and the enterprises included in the consolidation taken as a whole. The Hague, 5 August 2026
David Knibbe CEO, Chair of the Executive Board
Annemiek van Melick CFO, Vice-chair of the Executive Board
Condensed consolidated interim accounts Condensed consolidated balance sheetamounts in EUR million, unless stated otherwise
notes 30 June 2026
31 December
2025
Equity | ||
Shareholders' equity | 19,254 | 19,078 |
Minority interests | 101 | 93 |
Undated subordinated notes | 1,750 | 1,984 |
Total equity 8 | 21,105 | 21,155 |
Liabilities | ||
Insurance contracts 9 | 144,617 | 140,940 |
Investment contracts | 4,186 | 3,989 |
Reinsurance contracts | 63 | 69 |
Insurance, investment and reinsurance contracts | 148,866 | 144,998 |
Debt instruments issued | 1,197 | 1,197 |
Subordinated debt 10 | 2,348 | 2,348 |
Other borrowed funds | 9,300 | 9,875 |
Customer deposits | 18,197 | 17,915 |
Funding | 31,042 | 31,335 |
Derivatives 11 | 2,703 | 4,360 |
Deferred tax liabilities | 636 | 616 |
Other liabilities 12 | 2,681 | 2,448 |
Other | 6,020 | 7,424 |
Total liabilities | 185,928 | 183,757 |
Total equity and liabilities | 207,033 | 204,912 |
notes 30 June 2026
31 December
2025
Assets | ||
Cash and cash equivalents | 7,265 | 6,404 |
Investments at fair value through Other Comprehensive Income 2 | 98,084 | 99,469 |
Investments at cost 3 | 22,900 | 22,374 |
Investments at fair value through profit or loss 4 | 59,674 | 56,570 |
Investments in real estate | 2,082 | 2,234 |
Investments in associates and joint ventures 5 | 8,592 | 8,074 |
Derivatives 11 | 1,130 | 1,330 |
Investments | 199,727 | 196,455 |
Insurance contracts 9 | 519 | 480 |
Reinsurance contracts | 790 | 552 |
Insurance and reinsurance contracts | 1,309 | 1,032 |
Property and equipment | 312 | 313 |
Intangible assets 6 | 1,158 | 1,189 |
Deferred tax assets | 93 | 201 |
Other assets 7 | 4,434 | 5,722 |
Other | 5,997 | 7,425 |
Total assets | 207,033 | 204,912 |
References relate to the notes starting with Note 1 Accounting policies. These form an integral part of the Condensed consolidated interim accounts.
Condensed consolidated profit and loss accountnotes
1 January to
30 June 2026
1 January to
30 June 2025
notes
1 January to
30 June 2026
1 January to
30 June 2025
Fee and commission result | 288 | 227 |
Result on disposals of group companies | -131 | |
Non-attributable operating expenses 17 | -686 | -683 |
Other | 59 | 63 |
Net other result | -339 | -524 |
Result before tax | 1,351 | 528 |
Taxation | 277 | 132 |
Net result | 1,074 | 396 |
Net result 1 January to 30 June 2026 | 1 January to 30 June 2025 | |
Net result attributable to: | ||
Shareholders of the parent | 1,066 | 391 |
Minority interests | 8 | 5 |
Net result | 1,074 | 396 |
Release of contractual service margin | 523 | 449 |
Release of risk adjustment | 66 | 77 |
Expected claims and benefits | 2,918 | 2,782 |
Expected attributable expenses | 635 | 653 |
Recovery of acquisition costs | 225 | 224 |
Experience adjustments for premiums | 24 | 19 |
Insurance income Premium Allocation Approach | 1,581 | 1,483 |
Insurance income 13 | 5,972 | 5,687 |
Incurred claims and benefits | 2,903 | 2,789 |
Incurred attributable expenses | 655 | 646 |
Amortisation of acquisition costs | 225 | 224 |
Changes in incurred claims and benefits previous years | -7 | 6 |
(Reversal of) losses on onerous contracts | 56 | 36 |
Insurance expenses Premium Allocation Approach | 1,293 | 1,263 |
Insurance expenses 14 | 5,125 | 4,964 |
Net insurance result | 847 | 723 |
Net reinsurance result | -127 | -87 |
Net insurance and reinsurance result | 720 | 636 |
Investment income | 2,365 | 2,458 |
Gains (losses) on investments | 4,079 | -585 |
Other investment result | 283 | -185 |
Net investment result 15 | 6,727 | 1,688 |
Finance result on (re)insurance contracts 16 | 5,147 | 658 |
Result on investment contracts | 5 | 5 |
Finance result other | 605 | 609 |
Other finance result | 5,757 | 1,272 |
Net investment result | 970 | 416 |
Amounts in euro per ordinary share notes
1 January to
30 June 2026
1 January to
30 June 2025
Basic earnings per ordinary share 18 | 3.93 | 1.31 |
Diluted earnings per ordinary share 18 | 3.92 | 1.31 |
Net result | 1,074 | 396 |
- finance result on insurance contracts, recognised in OCI | -491 | 2,277 |
- finance result on reinsurance contracts, recognised in OCI | 12 | -48 |
- revaluations on debt securities at fair value through OCI | -194 | -943 |
- revaluations on loans at fair value through OCI | 22 | -89 |
- realised gains (losses) transferred to the profit and loss account | 332 | 168 |
- changes in cash flow hedge reserve | 283 | -1,211 |
- share of OCI of investments in associates and joint ventures | -4 | |
- foreign currency exchange differences | -20 | 78 |
Items that may be reclassified subsequently to the profit and loss account: | -60 | 232 |
- revaluations on equity securities at fair value through OCI | 1 | -48 |
- revaluations on property in own use | 2 | |
- remeasurement of the net defined benefit asset/liability | 6 | 6 |
Items that will not be reclassified to the profit and loss account: | 7 | -40 |
Total Other Comprehensive Income | -53 | 192 |
Total comprehensive income | 1,021 | 588 |
1 January to 30 June 2026 1 January to 30 June 2025
1 January to 30 June 2026 1 January to 30 June 2025
Comprehensive income attributable to: | ||
Shareholders of the parent | 1,013 | 583 |
Minority interests | 8 | 5 |
Total comprehensive income | 1,021 | 588 |
Reference is made to Note 20 Taxation for the disclosure on the income tax effects on each component of
comprehensive income.
Condensed consolidated statement of cash flows1 January to
30 June 2026
1 January to
30 June 2025
1 January to
30 June 2026
1 January to
30 June 2025
Disposals and redemptions: | ||
- group companies, net of cash disposed | -8 | |
- investments at fair value through OCI | 9,251 | 10,228 |
- investments at cost | 34 | 67 |
- investments at fair value through profit or loss | 6,201 | 5,843 |
- investments in associates and joint ventures | 133 | 119 |
- investments in real estate | 172 | 200 |
- other investments | 14 | |
Net cash flow from investing activities | 2,498 | -197 |
Proceeds from issuance of undated subordinated notes | 1,000 | |
Repayments of undated subordinated notes | -237 | -775 |
Proceeds from other borrowed funds | 3,453 | 7,087 |
Repayments of other borrowed funds | -4,031 | -5,550 |
Dividend paid | -655 | -574 |
Sale (purchase) of treasury shares | -135 | -137 |
Coupon on undated subordinated notes | -53 | -46 |
Net cash flow from financing activities | -1,658 | 1,005 |
Net cash flow | 863 | 858 |
Result before tax | 1,351 | 528 |
Adjusted for: | ||
- depreciation and amortisation on (in)tangible assets | 65 | 68 |
- changes in (re)insurance and investment contracts | 4,565 | 6 |
- (un)realised results and impairments on investments | -4,282 | 585 |
- other | -238 | 595 |
Net premiums, claims, and attributable expenses on (re)insurance contracts | -1,595 | -1,282 |
Tax (received) paid | -79 | -12 |
Changes in: | ||
- derivatives | -1,331 | 297 |
- investments at cost | -490 | -191 |
- other assets | 1,579 | 433 |
- customer deposits | 125 | 243 |
- other liabilities | 353 | -1,220 |
Net cash flow from operating activities | 23 | 50 |
Investments and advances: | ||
- investments at fair value through OCI | -7,813 | -10,016 |
- investments at cost | -38 | -75 |
- investments at fair value through profit or loss | -4,840 | -6,026 |
- investments in associates and joint ventures | -550 | -472 |
- investments in real estate | -31 | -43 |
- other investments | -21 | -28 |
1 January to
30 June 2026
1 January to
30 June 2025
Interest received | 2,390 | 2,524 |
Interest paid | -687 | -770 |
Dividend received | 367 | 404 |
1 January to
30 June 2026
1 January to
30 June 2025
Changes in Cash and cash equivalents - opening balance | 6,404 | 6,929 |
Net cash flow | 863 | 858 |
Effect of foreign currency exchange differences on cash and cash equivalents | -2 | -27 |
Changes in Cash and cash equivalents - closing balance | 7,265 | 7,760 |
Share capital Share premium Reserves
Total Shareholders'
equity (parent) Minority interest
Undated subordinated
notes Total equity
Balance at 1 January 2026
Finance result on insurance contracts recognised in OCI Finance result on reinsurance contracts recognised in OCI Revaluations on debt securities at fair value through OCI Revaluations on loans at fair value through OCI
Realised gains (losses) transferred to the profit and loss account Changes in cash flow hedge reserve
Share of OCI of investments in associates and joint ventures Foreign currency exchange differences
Revaluations on equity securities at fair value through OCI Remeasurement of the net defined benefit asset/liability Total amount recognised directly in equity OCI
Net result for the period Total comprehensive income
Issuance (redemption) of undated subordinated notes Dividend
Sale (purchase) of treasury shares Employee stock option and share plans Coupon on undated subordinated notes
Changes in the composition of the group and other changes
Balance at 30 June 2026
32 12,581
0 0
0 0
32 12,581
6,465
-491
12
-194
22
332
283
-4
-20
1
6
-53
1,066
1,013
-654
-135
1
-39
-10
6,641
19,078
-491
12
-194
22
332
283
-4
-20
1
6
-53
1,066
1,013
0
-654
-135
1
-39
-10
19,254
93
0
8
8
-1
1
101
1,984
0
0
-234
1,750
21,155
-491
12
-194
22
332
283
-4
-20
1
6
-53
1,074
1,021
-234
-655
-135
1
-39
-9
21,105
Condensed consolidated statement of changes in equity (2025) | |||||||
Share capital | Share premium | Reserves | Total Shareholders' equity (parent) | Minority interest | Undated subordinated notes | Total equity | |
Balance at 1 January 2025 | 32 | 12,581 | 7,218 | 19,831 | 85 | 1,736 | 21,652 |
Finance result on insurance contracts recognised in OCI | 2,277 | 2,277 | 2,277 | ||||
Finance result on reinsurance contracts recognised in OCI | -48 | -48 | -48 | ||||
Revaluations on debt securities at fair value through OCI | -943 | -943 | -943 | ||||
Revaluations on loans at fair value through OCI | -89 | -89 | -89 | ||||
Realised gains (losses) transferred to the profit and loss account | 168 | 168 | 168 | ||||
Changes in cash flow hedge reserve | -1,211 | -1,211 | -1,211 | ||||
Foreign currency exchange differences | 78 | 78 | 78 | ||||
Revaluations on equity securities at fair value through OCI | -48 | -48 | -48 | ||||
Remeasurement of the net defined benefit asset/liability | 6 | 6 | 6 | ||||
Revaluations on property in own use | 2 | 2 | 2 | ||||
Total amount recognised directly in equity OCI 0 | 0 | 192 | 192 | 0 | 0 | 192 |
Net result for the period | 391 | 391 | 5 | 396 | ||
Total comprehensive income 0 | 0 | 583 | 583 | 5 | 0 | 588 |
Issuance (redemption) of undated subordinated notes | 0 | 248 | 248 | |||
Dividend | -574 | -574 | -574 | |||
Sale (purchase) of treasury shares | -137 | -137 | -137 | |||
Coupon on undated subordinated notes | -42 | -42 | -42 | |||
Balance at 30 June 2025 32 | 12,581 | 7,048 | 19,661 | 90 | 1,984 | 21,735 |
-
Accounting policies
Basis of preparation
These Condensed consolidated interim accounts are prepared in accordance with IAS 34. The accounting principles used in these Condensed consolidated interim accounts comply with International Financial Reporting Standards as adopted by the European Union (IFRS-EU) and are consistent with those set out in the notes to the 2025 NN Group Consolidated annual accounts, except as set out below.
In these Condensed consolidated interim accounts, 'NN' refers to NN Group N.V. (the parent company) and/ or NN Group N.V. together with its consolidated subsidiaries (the consolidated group). These Condensed consolidated interim accounts should be read in conjunction with the 2025 NN Group Consolidated
annual accounts.
IFRS-EU provides a number of options in accounting policies. NN Group's accounting policies under IFRS-EU and its decision on the options available are set out in Note 1 'Accounting policies' and other applicable notes of the 2025 NN Group Consolidated annual accounts and below where different.
Certain amounts recorded in the Condensed consolidated interim accounts reflect estimates and assumptions made by management. Actual results may differ from the estimates made. Interim results are not necessarily indicative of full-year results.
The presentation of, and certain terms used in, the Condensed consolidated balance sheet, Condensed consolidated profit and loss account, Condensed consolidated statement of cash flows, Condensed consolidated statement of changes in equity and the notes was changed to provide additional and more relevant information or (for changes in comparative information) to better align with the current period presentation. The impact of these changes is explained in the respective notes when significant.
Changes in IFRS-EU effective in 2026
The following changes to existing standards became effective in 2026:
Annual Improvements Volume 11 (issued on 18 July 2024)
Contracts Referencing Nature-dependent Electricity -Amendments to IFRS 9 and IFRS 7 (issued on
18 December 2024)
Amendments to the Classification and Measurement of Financial Instruments-Amendments to IFRS 9 and IFRS 7 (issued on 30 May 2024)
These changes had no material impact on NN's Condensed consolidated interim accounts.
-
Investments at fair value through Other Comprehensive Income
Investments at fair value through other comprehensive income
Debt securities
60,732
61,063
Equity securities
2,183
2,585
Loans
35,169
35,821
Investments at fair value through Other Comprehensive Income
98,084
99,469
Changes in Investments at fair value through Other Comprehensive Income (2026)
Equity
30 June 2026 Debt securities securities Loans
Total
Investments at fair value through OCI - opening balance
61,063
2,585
35,821
99,469
Additions
6,688
3
1,122
7,813
Disposals and redemptions
-7,035
-424
-1,792
-9,251
Revaluations
-126
27
23
-76
Impairments and reversal of impairments
4
-1
3
Amortisation
41
-9
32
Foreign currency exchange differences
97
-8
5
94
Investments at fair value through OCI -closing balance
60,732
2,183
35,169
98,084
30 June 2026
31 December
2025
Changes in Investments at fair value through Other Comprehensive Income (2025)
Equity
31 December 2025
Debt securities
securities
Loans
Total
Investments at fair value through OCI - opening balance
65,198
3,110
37,742
106,050
Additions
14,579
90
2,444
17,113
Disposals and redemptions
-14,099
-409
-3,887
-18,395
Revaluations
-2,546
-222
-397
-3,165
Impairments and reversal of impairments
-19
-7
-26
Amortisation
50
-47
3
Foreign currency exchange differences
-2,100
16
-27
-2,111
Impairment - Investments at fair value through Other Comprehensive Income (2025)
Stage 1
Stage 2
Stage 3
31 December 2025
12 month expected credit
losses
Lifetime expected credit
losses
Lifetime expected credit
losses
Total
Impairments - Investments at fair value through OCI and
loans - opening balance
-30
-18
-60
-108
Transfers between stage 1,2 and 3
-1
6
-5
0
Additions
-6
-12
-8
-26
Disposals
7
5
14
26
Impairments - Investments at fair value through OCI
and loans - closing balance -30
-19
-59
-108
The loss allowance for investments at fair value through Other Comprehensive Income of EUR 76 million (2025: EUR 108 million) does not reduce the carrying amount of these investments (which are measured at fair value) but gives rise to an equal and opposite gain in Other Comprehensive Income and is included in the line 'Revaluations' in the table of Changes in investments at fair value through Other Comprehensive Income.
-
Investments at cost
Investments at fair value through OCI -
closing balance 61,063
2,585
35,821
99,469
Impairment - Investments at fair value through Other Comprehensive Income (2026)
Stage 1 Stage 2 Stage 3
12 month Lifetime Lifetime expected credit expected credit expected credit
30 June 2026 losses losses losses
Total
Impairments - Investments at fair value through OCI and loans - opening balance
-30
-19
-59
-108
Additions
4
-1
3
Disposals
4
2
23
29
Impairments - Investments at fair value through OCI and loans - closing balance
-22
-17
-37
-76
Investments at cost
30 June 2026
31 December
2025
Mortgage loans
22,847
22,323
Other
57
53
Impairments
-4
-2
Investments at cost - net of impairments
22,900
22,374
Changes in Investments at cost (2026)
Investments at cost - opening balance
22,320
54
22,374
Additions
1,597
38
1,635
Disposals and redemptions
-1,106
-35
-1,141
Fair value changes recognised on hedged items
43
43
Impairments and reversal of impairments
-2
-2
Amortisation
-9
-9
Investments at cost - closing balance
22,843
57
22,900
Changes in Investments at cost (2025)
31 December 2025
Mortgage loans
Other
Total
Investments at cost - opening balance
22,179
55
22,234
Additions
2,554
82
2,636
Disposals and redemptions
-2,098
-83
-2,181
Fair value changes recognised on hedged items
-291
-291
Amortisation
-24
-24
Investments at cost - closing balance
22,320
54
22,374
30 June 2026 Mortgage loans Other Total
-
Investments at fair value through profit or loss
Investments at fair value through profit or loss
30 June 2026
31 December
2025
For risk of policyholders:
- debt securities
597
650
- equity securities and investment funds
48,124
44,737
- loans and other
2,511
2,538
Total for risk of policyholders
51,232
47,925
For risk of company:
- debt securities
451
470
- equity securities and investment funds
7,642
7,761
- loans and other
349
414
Total for risk of company
8,442
8,645
Investments at fair value through profit or loss
59,674
56,570
-
Investments in associates and joint ventures
30 June 2026 30 June 2026
Balance sheet
31 December
2025
31 December
2025
Balance sheet
Investments in associates and joint ventures
30 June 2026 30 June 2026
Balance sheet
31 December
2025
31 December
2025
Balance sheet
Interest held
value Interest held
value
Interest held
value Interest held
value
Dutch Climate Action Fund Equity Vintage 1 C.V.
97%
114
97%
100
Hayfin TS Feeder (Parallel) Dutch SCSp
79%
106
79%
97
Fiumaranuova s.r.l.
50%
100
50%
98
Delta Mainlog Holding GmbH & Co. KG
50%
85
50%
77
CRE Senior Debt SCA SICAV-RAIF - CRE Senior 17
40%
76
40%
66
Boccaccio - Closed-end Real Estate Mutual Investment Fund
50%
76
50%
75
NL Boompjes Property 5 C.V.
50%
72
50%
69
Octopus Commercial Real Estate Debt Fund III LP
46%
71
46%
88
ION Residential Platform NV
48%
64
48%
52
Crescent ESL Saffron SCSp
100%
63
100%
34
CBRE Property Fund Central and Eastern Europe FGR
50%
61
50%
64
Prime Ventures V C.V.
18%
57
18%
62
17 Capital Credit 2 EUR Feeder (2) SCSP
40%
52
44%
2
Other
670
605
Investments in associates and joint ventures
8,592
8,074
Vesteda Residential Fund FGR, The Netherlands
24%
1,970
24%
1,895
Hayfin Amber ScSp
100%
561
100%
368
Macquarie European Infrastructure Debt Fund
44%
395
44%
372
Nestar Residencial S.I.I. S.A.
27%
309
27%
310
Rivage Euro Debt infrastructure 3
34%
296
34%
301
CBRE Dutch Residential Fund I FGR
10%
273
9%
265
Rivage Priv. Debt - Fund for Infrastructure Climate Solutions
99%
261
100%
237
CBRE Retail Property Fund Iberica L.P.
50%
251
50%
256
Rivage Euro Debt Infrastructure High return 2
34%
231
34%
220
CBRE Dutch Office Fund FGR
19%
215
19%
227
Ardstone Residential Income Fund
21%
212
21%
208
Bentall Green Oak Europe Secured Lending III SLP
33%
198
33%
207
Macquarie Climate Investments Debt Fund
100%
194
100%
189
Healthcare Activos SOCIMI S.A.
38%
191
38%
185
Dutch Urban Living Venture FGR
49%
186
49%
173
NRP Nordic Logistic Fund SA
42%
183
42%
187
Rivage Hopitaux Publics Euro
34%
183
34%
193
Dutch Student and Young Professional Housing Fund FGR
49%
162
49%
153
Macquarie Direct Lending Europe SCSp
56%
147
90%
188
DPE Deutschland III (Parallel) GmbH & Co
17%
138
17%
90
AXA CITRUS CRE Enhanced SMA
100%
133
100%
124
Allee center Kft
50%
121
50%
121
CBRE Dutch Retail Fund FGR
22%
115
22%
116
The above investments in associates and joint ventures mainly consist of non-listed investment entities investing in real estate and private equity. Therefore, the assets and liabilities are mainly non-current.
Significant influence exists for certain associates in which the interest held is below 20%, based on the combination of NN's financial interest for own risk and other arrangements, such as participation in the relevant boards.
NN holds associates over which it cannot exercise control despite holding more than 50% of the share capital. For this reason, these are classified as associates and are not consolidated.
Other includes EUR 601 million (2025: EUR 535 million) of associates and joint ventures with an individual balance sheet value of less than EUR 50 million and EUR 69 million (2025: EUR 70 million) of receivables from associates and joint ventures.
The amounts presented in the table above could differ from the individual annual accounts of the associates due to the fact that the individual amounts have been brought in line with NN's accounting principles.
The reporting dates of all significant associates and joint ventures are consistent with the reporting date of NN.
The associates and joint ventures of NN are subject to legal and regulatory restrictions regarding the amount of dividends that can be paid to NN. These restrictions are, for example, dependent on the laws in the country of incorporation for declaring dividends or as a result of minimum capital requirements imposed by industry regulators in the countries in which the associates and joint ventures operate. In addition, the associates and joint ventures also consider other factors in determining the appropriate levels of equity needed. These factors and limitations include, but are not limited to, rating agency and regulatory views, which can change over time.
- Intangible assets
- Other assets
Other assets
30 June 2026
31 December
2025
30 June 2026
31 December
Income tax receivable | 98 | 50 |
Accrued interest and rents | 1,066 | 1,342 |
Other accrued assets | 379 | 268 |
Cash collateral amounts paid | 2,266 | 3,405 |
Other | 625 | 657 |
Other assets | 4,434 | 5,722 |
8 Equity Total equity 30 June 2026 | 31 December 2025 | |
Share capital | 32 | 32 |
Share premium | 12,581 | 12,581 |
Accumulated revaluations on investments | -7,741 | -8,095 |
Accumulated revaluations on (re)insurance contracts | 15,805 | 16,284 |
Foreign currency translation reserve | -502 | -482 |
Net defined benefit asset/liability remeasurement reserve | -37 | -42 |
Other reserves | -884 | -1,200 |
Shareholders' equity (parent) | 19,254 | 19,078 |
Minority interests | 101 | 93 |
Undated subordinated notes | 1,750 | 1,984 |
Total equity | 21,105 | 21,155 |
2025
Goodwill | 870 | 875 |
Software | 75 | 82 |
Other | 213 | 232 |
Total | 1,158 | 1,189 |
Changes in Shareholders' equity (parent) (2026)
30 June 2026 Share capital Share premium Reserves
Total shareholders' equity (parent)
Coupon paid on Undated subordinated notes (2026)
The Undated subordinated notes have optional semi-annual coupon payments in March and September. The coupon payments are deducted from equity.
Shareholders' equity (parent) - opening balance | 32 | 12,581 | 6,465 | 19,078 |
Total amount recognised directly in equity (Other Comprehensive Income) | -53 | -53 | ||
Net result for the period | 1,066 | 1,066 | ||
Dividend | -654 | -654 | ||
Sale (purchase) of treasury shares | -135 | -135 | ||
Employee stock option and share plans | 1 | 1 | ||
Coupon on undated subordinated notes | -39 | -39 | ||
Changes in the composition of the group and other changes | -10 | -10 | ||
Shareholders' equity (parent) - closing balance | 32 | 12,581 | 6,641 | 19,254 |
Changes in Shareholders' equity (parent) (2025)
31 December 2025 Share capital Share premium Reserves
Total shareholders' equity (parent)
Sale (purchase) of treasury shares (2026)
During 2026, 1,932,189 ordinary shares for a total amount of EUR 135 million were repurchased under the open market share buyback programme. Treasury shares for a total amount of EUR 2 million were delivered under Employee share plans.
In 2026, no NN Group N.V. treasury shares were cancelled.
As at 30 June 2026, 2,650,780 treasury shares were held by NN Group N.V.
Interim dividend (2026)
NN Group announced today that it will pay an interim dividend of EUR 1.55 per ordinary share, or approximately EUR 403 million in total based on the current number of outstanding shares (net of treasury shares), calculated as 40% of the 2025 full-year dividend per ordinary share in accordance with the NN Group dividend policy. The interim dividend will be paid fully in cash, after deduction of withholding tax if applicable.
Redemption undated notes
On 15 January 2026, the first call date, NN called and redeemed the outstanding EUR 237 million of undated subordinated notes, issued in 2014. NN announced the early redemption on 16 December 2025.
Shareholders' equity (parent) - opening balance 32 12,581 7,218 19,831
Total amount recognised directly in equity (Other
Comprehensive Income) -620 -620
Net result for the period 1,188 1,188
Dividend -939 -939
Sale (purchase) of treasury shares -298 -298
Employee stock option and share plans 2 2
Coupon on undated subordinated notes -86 -86
Shareholders' equity (parent) - closing balance 32 | 12,581 | 6,465 | 19,078 |
Sale (purchase) of treasury shares (2025)
During 2025, 5,358,132 ordinary shares for a total amount of EUR 298 million were repurchased under the open market share buyback programme. Treasury shares for a total amount of EUR 2 million were delivered under Employee share plans.
In 2025, 6,000,000 NN Group N.V. treasury shares were cancelled.
As at 31 December 2025, 811,127 treasury shares were held by NN Group N.V.
Interim dividend (2025)
NN Group N.V. paid an interim dividend of EUR 1.38 per ordinary share, or EUR 365 million in total, calculated as 40% of the 2024 full-year dividend per ordinary share in accordance with the NN dividend policy. The interim dividend was paid fully in cash, after deduction of withholding tax if applicable.
Proposed final dividend (2025)
At the Annual General Meeting on 21 May 2026, a final dividend was proposed of EUR 2.50 per ordinary share, or approximately EUR 655 million in total based on the number of outstanding shares on the date of the announcement (net of treasury shares). The final dividend was paid in cash, after deduction of withholding tax if applicable.
The final dividend was adopted by the General Meeting at the annual general meeting held on 21 May 2026.
Undated subordinated notes (2025)
In March 2025, NN Group N.V. announced a tender for purchase by NN Group N.V. of the EUR 1 billion Fixed to Floating Rate Undated subordinated notes for cash at a price of 101.6% of the nominal amount. The tender was completed in March 2025 and NN Group N.V. accepted the purchase of EUR 763 million in nominal amount.
In March 2025 NN Group N.V. issued euro-denominated, perpetual, restricted Tier 1, temporary write-down securities for an amount of EUR 1 billion. The notes are first callable on 11 September 2034. The coupon is fixed at 5.75% per annum until 11 March 2035 and will be reset every fifth year thereafter.
Coupon paid on Undated subordinated notes (2025)
-
Insurance contracts
Discount rates
Discount rates are determined using a liquid risk-free curve to which an illiquidity premium is added. The liquid risk-free curve is set per currency, while the illiquidity premium is determined per entity using an approach that reflects the characteristics of the current assets of that entity. Spreads used in the illiquidity premium
are derived from fixed income assets using Z-spreads. The total asset spread is adjusted for expected and unexpected credit losses.
For the Euro currency, the risk-free curve is based on the swap rate and includes a last liquid point (LLP) of 30 years and a long-term forward rate (LTFR). At 30 June 2026 the LTFR was 3.20% (31 December 2025: 3.20%).
The table below sets out the yield curves used to discount the cash flows of insurance contracts for NN's largest segment, Netherlands Life.
Range of yield curves
General Model Variable Fee Approach
The Undated subordinated notes have an optional annual coupon payment in July and optional semi-annual coupon payments in March and September. The annual coupon resulted in a deduction of EUR 86 million (net of tax) from equity.
Minority interest
NN Group N.V. owns 51% of the shares of Nationale-Nederlanden ABN AMRO Verzekeringen Holding B.V. (ABN AMRO Verzekeringen). ABN AMRO Verzekeringen's principal place of business is Zwolle, the Netherlands.
ABN AMRO Verzekeringen is fully consolidated by NN Group N.V., with a minority interest recognised of 49%. At 30 June 2026, the minority interest relating to ABN AMRO Verzekeringen recognised in equity was
1 year
3.3%
2.7%
2.7%
2.2%
5 years
3.3%
3.1%
2.7%
2.5%
10 years
3.5%
3.5%
2.9%
2.9%
20 years
3.7%
3.8%
3.1%
3.3%
30 years
3.6%
3.8%
3.0%
3.2%
40 years
3.5%
3.7%
3.0%
3.2%
30 June 2026
31 December
2025 30 June 2026
31 December
2025
EUR 94 million (2025: EUR 87 million).
For the other insurance segments within the group, the same risk-free curve is used, but the illiquidity premium is derived from the asset portfolios for specific entities, resulting in a range of yield curves used.
Insurance contracts
Insurance contracts (2026)
30 June 2026 General Model
Variable Fee Approach
Total General Model and Variable Fee Approach
Premium Allocation
Approach Total
Insurance contracts (2025)
31 December 2025 General Model
Life insurance contracts for risk
Variable Fee Approach
Total General Model and Variable Fee Approach
Premium Allocation
Approach Total
Life insurance contracts for risk of company
86,722
1,933
88,655
1
88,656
Life insurance contracts for risk of policyholders
4,967
43,173
48,140
48,140
Life insurance contracts
91,689
45,106
136,795
1
136,796
Non-life contracts for remaining coverage
4,300
4,300
415
4,715
Non-life contracts for incurred claims and benefits
92
92
2,495
2,587
Non-life insurance contracts
4,392
0
4,392
2,910
7,302
Total insurance contracts
96,081
45,106
141,187
2,911
144,098
- of which presented as assets
515
4
519
519
- of which presented as liabilities
96,596
45,110
141,706
2,911
144,617
Total insurance contracts
96,081
45,106
141,187
2,911
144,098
of company 86,812 1,775 88,587 88,587
Life insurance contracts for risk
of policyholders 6,023 39,030 45,053 45,053
Life insurance contracts
92,835
40,805
133,640
0
133,640
Non-life contracts for remaining coverage
4,039
4,039
248
4,287
Non-life contracts for incurred claims and benefits
85
85
2,448
2,533
Non-life insurance contracts
4,124
0
4,124
2,696
6,820
Total insurance contracts
96,959
40,805
137,764
2,696
140,460
- of which presented as assets
474
6
480
480
- of which presented as liabilities
97,433
40,811
138,244
2,696
140,940
Total insurance contracts
96,959
40,805
137,764
2,696
140,460
General Model and Variable Fee Approach
Insurance contracts under General Model and Variable Fee Approach (2026)
30 June 2026 Estimates of the present value of future cash flows Risk adjustment for non-financial risk Contractual service margin Total General Model and Variable Fee Approach
- opening balance presented as assets
1,378
-100
-798
480
- opening balance presented as liabilities
129,089
1,105
8,050
138,244
Net opening balance
127,711
1,205
8,848
137,764
- insurance contracts initially recognised in the year
-519
51
484
16
- changes in estimates that adjust the contractual service margin
-17
-5
22
0
- changes in estimates that do not adjust the contractual service margin
45
5
50
Changes that relate to future service
-491
51
506
66
- release to profit or loss
-66
-523
-589
- experience adjustments not adjusting the contractual service margin
-29
-29
Changes that relate to current service
-29
-66
-523
-618
- changes in incurred claims and benefits previous years
-7
-7
Changes that relate to past service
-7
0
0
-7
- finance result through profit or loss
5,066
9
50
5,125
- finance result recognised in OCI
622
6
628
Finance result on insurance contracts
5,688
15
50
5,753
- premiums received
5,431
5,431
- acquisition costs paid
-353
-353
- claims, benefits and attributable expenses paid
-6,797
-6,797
Cash flows
-1,719
0
0
-1,719
Foreign currency exchange differences
-48
-3
-1
-52
Net closing balance
131,105
1,202
8,880
141,187
- closing balance presented as assets
1,470
-107
-844
519
- closing balance presented as liabilities
132,575
1,095
8,036
141,706
Net closing balance
131,105
1,202
8,880
141,187
Insurance contracts under General Model and Variable Fee Approach (2025)
31 December 2025 Estimates of the present value of future cash flows Risk adjustment for non-financial risk Contractual service margin Total General Model and Variable Fee Approach
opening balance presented as assets 1,158 -89 -660 409
Net opening balance
135,331
1,289
7,950
144,570
opening balance presented as liabilities 136,489 1,200 7,290 144,979
insurance contracts initially recognised in the year -828
changes in estimates that adjust the contractual service margin -1,243
changes in estimates that do not adjust the contractual service margin 42
Changes that relate to future service -2,029
release to profit or loss
experience adjustments not adjusting the contractual service margin -88
Changes that relate to current service -88
changes in incurred claims and benefits previous years 5
Changes that relate to past service 5
finance result through profit or loss 3,977
finance result recognised in OCI -4,534
Finance result on insurance contracts -557
premiums received 10,260
acquisition costs paid -673
claims, benefits and attributable expenses paid -13,382
Cash flows
-3,798
0
-5
-3,803
changes in the composition of the group and other changes -3
83
137
-9
211
-142
-142
-1
-1
29
-148
-119
788
1,106
1,894
-999
-999
0
92
92
-5
43
0
33
76
-1,141
-88
-1,229
4
4
4,098
-4,682
-584
10,260
-673
-13,382
-8
Other movements 3 -2 1
Foreign currency exchange differences -1,156
-31 -84 -1,271
Net closing balance
127,711
1,205
8,848
137,764
closing balance presented as assets 1,378
-100
-798
480
closing balance presented as liabilities 129,089
1,105 8,050 138,244
Net closing balance
127,711
1,205
8,848 137,764
Insurance contracts recognised in the period (2026)
Onerous
Other Insurance
Insurance
Total Insurance
Composition of underlying items for insurance contracts
31 December
- debt securities
559
611
- equity securities and investment funds
45,248
42,073
- loans and other
2,333
2,369
Total
48,140
45,053
Contractual service margin
Disaggregation of the contractual service margin by transition approach (2026)
Contract issued after
transition and full Modified
retrospective retrospective Fair value
30 June 2026 approach approach approach
Total General Model and Variable Fee Approach
Disaggregation of the contractual service margin by transition approach - opening balance
2,975
676
5,197
8,848
- insurance contracts initially recognised in the year
484
484
- changes in estimates that adjust the contractual service margin
-109
73
58
22
Changes that relate to future service
375
73
58
506
- release to profit or loss
-265
-61
-197
-523
Changes that relate to current service
-265
-61
-197
-523
Finance result
27
3
20
50
Finance result through profit or loss
27
3
20
50
Foreign currency exchange differences
6
-6
-1
-1
Disaggregation of the contractual service margin by transition approach - closing balance
3,118
685
5,077
8,880
Insurance
contracts
contracts
contracts
Fair value of underlying items
30 June 2026
2025
contracts issued
issued
acquired
initially recognised
30 June 2026
Estimates of the present value of future cash inflows
-424
-5,441
0
-5,865
- acquisition costs
12
300
312
- claims, benefits and attributable expenses
427
4,607
5,034
Estimates of the present value of future cash outflows
439
4,907
0
5,346
Risk adjustment
1
50
51
Contractual service margin
484
484
Total insurance contracts initially recognised in the year
16
0
0
16
Insurance contracts recognised in the period (2025)
Onerous Insurance
31 December 2025 contracts issued
Other Insurance
contracts issued
Insurance contracts acquired
Total Insurance
contracts initially recognised
Estimates of the present value of future cash inflows
-630
-7,351
0
-7,981
- acquisition costs
31
556
587
- claims, benefits and attributable expenses
639
5,927
6,566
Estimates of the present value of future cash outflows
670
6,483
0
7,153
Risk adjustment
3
80
83
Contractual service margin
788
788
Total insurance contracts initially recognised in the year
43
0
0
43
Disaggregation of contractual service margin by transition approach (2025)
Contract issued after
Total General
The Contractual Service Margin by remaining term provides the expected maturity of the balance sheet amount of the Contractual Service Margin at the end of the period. The actual release of the Contractual
31 December 2025
Disaggregation of the contractual service margin by
transition and full retrospective
approach
Modified retrospective
approach
Fair value approach
Model and Variable Fee Approach
Service Margin that will be recognised in the profit and loss account in future years will differ as the release in future years will be impacted by the future development of the Contractual Service Margin due to new contracts sold, interest accreted and changes in estimates.
transition approach - opening balance 2,508 755 4,687 7,950
insurance contracts initially recognised in the year 788 788
changes in estimates that adjust the contractual
service margin 116 55 935 1,106
Changes that relate to future service
904
55
935
1,894
- release to profit or loss
-430
-124
-445
-999
Changes that relate to current service
-430
-124
-445
-999
Finance result
48
8
36
92
Finance result through profit or loss
48
8
36
92
Other movements
-5
-5
Foreign currency exchange differences
-50
-18
-16
-84
Disaggregation of the contractual service margin by transition approach - closing balance
2,975
676
5,197
8,848
Contractual service margin by remaining term
30 June 2026
31 December
2025
Less than 1 year
905
893
1-2 years
780
760
2-3 years
700
681
3-4 years
634
619
4-5 years
575
561
5-10 years
2,031
2,023
Over 10 years
3,255
3,311
Total
8,880
8,848
Liabilities for remaining coverage and incurred claims and benefits (2026)
Liability for remaining coverage Liability for incurred claims and benefits Total General Model and Variable Fee Approach
30 June 2026 Remaining coverage Loss component
- opening balance presented as assets
542
-8
-54
480
- opening balance presented as liabilities
136,533
301
1,410
138,244
Net opening balance
135,991
309
1,464
137,764
- release of contractual service margin
-523
-523
- release of risk adjustment
-66
-66
- expected claims and benefits
-2,918
-2,918
- expected attributable expenses
-635
-635
- recovery of acquisition costs
-225
-225
- experience adjustments for premiums that relate to current or past service
-24
-24
Insurance income
-4,391
0
0
-4,391
- incurred claims and benefits
2,903
2,903
- incurred attributable expenses
655
655
- amortisation of acquisition costs
225
225
- changes in incurred claims and benefits previous years
-7
-7
- (reversal of) losses on onerous contracts
56
56
Insurance expenses
225
56
3,551
3,832
Investment components excluded from insurance expenses and insurance income
-3,345
3,345
0
- finance result through profit or loss
5,120
2
3
5,125
- finance result recognised in OCI
613
15
628
Finance result on insurance contracts
5,733
2
18
5,753
- premiums received
5,431
5,431
- acquisition costs paid
-353
-353
- claims, benefits and attributable expenses paid
-6,797
-6,797
Cash flows
5,078
0
-6,797
-1,719
Liability for remaining coverage Liability for incurred claims and benefits Total General Model and Variable Fee Approach
30 June 2026 Remaining coverage Loss component
Foreign currency exchange differences
-46 -1
-5
-52
Net closing balance
139,245 366
1,576
141,187
- closing balance presented as assets
585 -6
-60
519
- closing balance presented as liabilities
139,830 360
1,516
141,706
Net closing balance
139,245 366
1,576
141,187
Remaining coverage includes risk adjustment and contractual service margin.
Net opening balance
142,658
272
1,640
144,570
- release of contractual service margin
-999
-999
- release of risk adjustment
-142
-142
- expected claims and benefits
-5,600
-5,600
- expected attributable expenses
-1,304
-1,304
- recovery of acquisition costs
-432
-432
- experience adjustments for premiums that relate to current or past service
-17
-17
Insurance income
-8,494
0
0
-8,494
- incurred claims and benefits
5,550
5,550
- incurred attributable expenses
1,322
1,322
- amortisation of acquisition costs
432
432
- changes in incurred claims and benefits previous years
4
4
- (reversal of) losses on onerous contracts
37
37
Insurance expenses
432
37
6,876
7,345
Investment components excluded from insurance expenses and insurance income
-6,397
6,397
0
- finance result through profit or loss
4,110
3
-15
4,098
- finance result recognised in OCI
-4,689
7
-4,682
Finance result on insurance contracts
-579
3
-8
-584
- premiums received
10,260
10,260
- acquisition costs paid
-673
-673
- claims, benefits and attributable expenses paid
-13,382
-13,382
- changes in the composition of the group and other changes
-5
-2
-1
-8
Cash flows
9,582
-2
-13,383
-3,803
Liabilities for remaining coverage and incurred claims and benefits (2025)
Liability for remaining coverage
Liability for incurred claims and benefits
Total General Model and Variable Fee Approach
31 December 2025
Remaining coverage
Loss component
- opening balance presented as assets
469
-9
-51
409
- opening balance presented as liabilities
143,127
263
1,589
144,979
Net closing balance
135,991
309
1,464
137,764
- closing balance presented as assets
542
-8
-54
480
- closing balance presented as liabilities
136,533
301
1,410
138,244
Net closing balance
135,991
309
1,464
137,764
Liability for remaining coverage
Liability for incurred claims and benefits
Total General Model and Variable Fee Approach
31 December 2025
Remaining coverage
Loss component
Other movements
1
1
Foreign currency exchange differences
-1,211
-1
-59
-1,271
Remaining coverage includes risk adjustment and contractual service margin.
Premium Allocation Approach
Liabilities for remaining coverage and incurred claims and benefits Premium Allocation Approach (2026)
Liability for remaining coverage Liability for incurred claims and benefits Total Premium Allocation Approach Estimates of the present value of
30 June 2026 Remaining coverage Loss component future cash flows Risk adjustment
- opening balance presented as assets
0
- opening balance presented as liabilities
247
4
2,344
101
2,696
Net opening balance
247
4
2,344
101
2,696
Insurance income
-1,581
-1,581
- incurred claims and benefits
844
3
847
- incurred attributable expenses
502
502
- amortisation of acquisition costs
1
1
- changes in incurred claims and benefits previous years
-1
-63
-64
- (reversal of) losses on onerous contracts
-1
-1
Insurance expenses
1
-1
1,345
-60
1,285
- finance result through profit or loss
22
22
- finance result recognised in OCI
-2
-2
Finance result on insurance contracts
0
0
20
0
20
- premiums received
1,749
1,749
- acquisition costs paid
-1
-1
- claims, benefits and attributable expenses paid
-1,257
-1,257
Cash flows
1,748
0
-1,257
0
491
Foreign currency exchange differences
-1
1
0
Net closing balance
414
3
2,452
42
2,911
- closing balance presented as assets
0
- closing balance presented as liabilities
414
3
2,452
42
2,911
Net closing balance
414
3
2,452
42
2,911
Liabilities for remaining coverage and incurred claims and benefits Premium Allocation Approach (2025)
Liability for remaining coverage Liability for incurred claims and benefits Total Premium Allocation Approach Estimates of the present value of
31 December 2025 Remaining coverage Loss component future cash flows Risk adjustment
opening balance presented as assets 0
opening balance presented as liabilities 225 2 2,295 40 2,562
Net opening balance
225 2
2,295
40
2,562
Insurance income
-3,023
-3,023
- incurred claims and benefits
1,570
5
1,575
- incurred attributable expenses
944
944
- amortisation of acquisition costs
4
4
- changes in incurred claims and benefits previous years
-21
59
38
- (reversal of) losses on onerous contracts
2
2
Insurance expenses
4
2
2,493
64
2,563
- finance result through profit or loss
36
36
- finance result recognised in OCI
5
5
Finance result on insurance contracts
0
0
41
0
41
- premiums received
3,044
3,044
- acquisition costs paid
-4
-4
- claims, benefits and attributable expenses paid
-2,486
-2,486
Cash flows
3,040
0
-2,486
0
554
Foreign currency exchange differences
1
1
-3
-1
Net closing balance
247
4
2,344
101
2,696
- closing balance presented as assets
0
- closing balance presented as liabilities
247
4
2,344
101
2,696
Net closing balance
247
4
2,344
101
2,696
-
Subordinated debt
The subordinated debt instruments have been issued to raise hybrid capital. Under IFRS-EU these debt instruments are classified as liabilities. They are considered capital for regulatory purposes. All subordinated debt is euro denominated.
-
Derivatives
Derivatives (assets)
-
Other liabilities
Other liabilities
30 June 2026
31 December
2025
Derivatives used in:
- fair value hedges
6
- cash flow hedges
196
94
- hedges of net investments in foreign operations
4
1
Other derivatives
930
1,229
Derivatives (assets)
1,130
1,330
Other derivatives comprises derivatives for which no hedge accounting is applied.
Derivatives (liabilities)
30 June 2026
31 December
2025
Derivatives used in:
- fair value hedges
4
- cash flow hedges
1,674
2,564
- hedges of net investments in foreign operations
1
2
Other derivatives
1,024
1,794
Derivatives (liabilities)
2,703
4,360
30 June 2026
31 December
Income tax payable
140
52
Net defined benefit liability
69
76
Other post-employment benefits
3
3
Other staff-related liabilities
87
85
Other taxation and social security contributions
108
105
Lease liabilities
273
269
Accrued interest
275
351
Costs payable
326
297
Provisions
137
382
Amounts to be settled
26
23
Cash collateral amounts received
364
208
Other
873
597
Other liabilities
2,681
2,448
2025
- Insurance income 14 Insurance expenses
Insurance income (2026)
1 January to 30 June 2026
Contracts issued after transition and full retrospective approach
Modified retrospective
approach
Fair value
approach Total
Insurance expenses General Model and Variable Fee Approach
1 January to
Incurred claims and benefits | 2,903 | 2,789 |
Incurred attributable expenses | 655 | 646 |
Amortisation of acquisition costs | 225 | 224 |
Changes in incurred claims and benefits previous years | -7 | 6 |
(Reversal of) losses on onerous contracts | 56 | 36 |
Insurance expenses General Model and Variable Fee Approach | 3,832 | 3,701 |
(Reversal of) losses on onerous contracts General Model and Variable Fee Approach 1 January to 30 June 2026 | 1 January to 30 June 2025 | |
Losses on onerous contracts initially recognised in the year | 16 | 27 |
Changes in estimates not adjusting the contractual service margin | 50 | 21 |
Expected claims and benefits attributed to the loss component | -1 | -5 |
Expected attributable insurance expenses attributed to the loss component | -9 | -7 |
(Reversal of) losses on onerous contracts General Model and Variable Fee Approach | 56 | 36 |
30 June 2026
1 January to
30 June 2025
Release of contractual service margin | 265 | 61 | 197 | 523 |
Release of risk adjustment | 23 | 7 | 36 | 66 |
Expected claims and benefits | 977 | 37 | 1,904 | 2,918 |
Expected attributable expenses | 343 | 49 | 243 | 635 |
Recovery of acquisition costs | 194 | 30 | 1 | 225 |
Experience adjustments for premiums that relate to current or past service | 24 | 24 | ||
Insurance income General Model and Variable Fee Approach | 1,826 | 184 | 2,381 | 4,391 |
Insurance income Premium Allocation Approach | 1,581 | |||
Total insurance income | 5,972 | |||
Insurance income (2025) 1 January to 30 June 2025 | Contracts issued after transition and full retrospective approach | Modified retrospective approach | Fair value approach | Total |
Release of contractual service margin | 203 | 63 | 183 | 449 |
Release of risk adjustment | 24 | 8 | 45 | 77 |
Expected claims and benefits | 628 | 41 | 2,113 | 2,782 |
Expected attributable expenses | 327 | 58 | 268 | 653 |
Recovery of acquisition costs | 184 | 39 | 1 | 224 |
Experience adjustments for premiums that relate to current or past service | 19 | 19 | ||
Insurance income General Model and Variable Fee Approach | 1,385 | 209 | 2,610 | 4,204 |
Insurance income Premium Allocation Approach | 1,483 | |||
Total insurance income | 5,687 | |||
Insurance expenses Premium Allocation Approach
1 January to
Incurred claims and benefits | 847 | 777 |
Incurred attributable expenses | 502 | 469 |
Amortisation of acquisition costs | 1 | 2 |
Changes in incurred claims and benefits previous years | -64 | 9 |
(Reversal of) losses on onerous contracts | -1 | |
Other insurance expenses | 8 | 6 |
Insurance expenses Premium Allocation Approach | 1,293 | 1,263 |
30 June 2026
1 January to
30 June 2025
15 Investment resultInvestment result
1 January to
30 June 2026
1 January to
30 June 2025
Interest income from investments in debt securities | 929 | 905 |
Interest income from mortgage loans | 712 | 704 |
Interest income from other loans | 142 | 147 |
Interest income on (hedging) derivatives | 274 | 296 |
Other interest income | 79 | 96 |
Interest income | 2,136 | 2,148 |
Income from investments in real estate | 48 | 52 |
Dividend income on equity securities | 177 | 255 |
Other investment income | 4 | 3 |
Total other investment income | 229 | 310 |
Investment income | 2,365 | 2,458 |
Realised gains (losses) on Investments at cost and at fair value through Other Comprehensive Income | -287 | -228 |
Gains (losses) on investments at fair value through profit or loss | 4,377 | -365 |
Gains (losses) on investments in real estate | -11 | 8 |
Gains (losses) on Investments at cost, at fair value through OCI and at fair value through profit and loss | 4,079 | -585 |
Share of result of investments in associates and joint ventures | 288 | 226 |
Impairments and reversal of impairments on investments | 1 | |
Result on derivatives and hedging | -194 | 575 |
Foreign currency exchange result | 188 | -986 |
Other investment result | 283 | -185 |
Net investment result | 6,727 | 1,688 |
Gains (losses) on investments at fair value through profit or loss include gains (losses) related to investments held for risk of policyholders for EUR 4,203 million (1 January to 30 June 2025: EUR -266 million). These
gains (losses) are mostly offset by changes in fair value of underlying items as presented in 'Finance result on (re)insurance contracts'.
Dividend income on equity securities includes EUR 34 million of dividend relating to equity securities at fair value through Other Comprehensive Income held at 30 June 2026 (30 June 2025: EUR 62 million) and EUR 8 million of dividend relating to equity securities at fair value through Other Comprehensive Income derecognised during 2026 (1 January to 30 June 2025: EUR 2 million).
Impairments and reversal of impairments on investments by segment
17 Non-attributable operating expensesNon-attributable operating expenses
1 January to
30 June 2026
1 January to
30 June 2025
1 January to
30 June 2026
1 January to
Staff expenses | 900 | 863 |
Other operating expenses | 1,299 | 1,268 |
Of which attributed to: | ||
- incurred acquisition costs | -348 | -325 |
- incurred insurance expenses | -1,165 | -1,123 |
Non-attributable operating expenses | 686 | 683 |
30 June 2025
Netherlands Life | -1 | 1 |
Netherlands Non-life | -1 | |
Japan Life | -2 | |
Banking | 1 | |
Total | -1 | -1 |
16 Finance result Finance result on (re)insurance contracts 1 January to 30 June 2026 | 1 January to 30 June 2025 | |
Change in fair value of underlying items | 4,232 | -266 |
Interest accreted | 916 | 925 |
Changes in value of options and guarantees for which the risk mitigation solution is used | -1 | -1 |
Finance result on (re) insurance contracts | 5,147 | 658 |
Earnings per ordinary share shows earnings per share amounts for profit or loss attributable to shareholders of the parent. Earnings per ordinary share is calculated on the basis of the weighted average number of ordinary shares outstanding. In calculating the weighted average number of ordinary shares outstanding, own shares held by group companies are deducted from the total number of ordinary shares in issue.
Changes in the number of ordinary shares outstanding without a corresponding change in resources are taken into account, including if these changes occurred after the reporting date but before the annual accounts are authorised for issue.
Earnings per ordinary share
Amounts (in millions of euro) Weighted average number of
ordinary shares (in millions)
Per ordinary share (in euro)
1 January to
30 June 2026
1 January to
30 June 2025
1 January to
30 June 2026
1 January to
30 June 2025
1 January to
30 June 2026
1 January to
30 June 2025
Net result | 1,066 | 391 | ||||
Coupon on undated subordinated notes | -39 | -41 | ||||
Basic earnings per ordinary share | 1,027 | 350 | 261.6 | 266.5 | 3.93 | 1.31 |
Dilutive instruments: | ||||||
- Share plans | 0.2 | 0.2 | ||||
Dilutive instruments | 0 | 0.2 | 0.2 | |||
Diluted earnings per ordinary share | 1,027 | 350 | 261.8 | 266.7 | 3.92 | 1.31 |
Diluted earnings per share is calculated as if the share plans had been exercised at the beginning of the period and assuming that the cash received from exercised share plans was used to buy own shares against the average market price during the period. The net increase in the number of shares resulting from exercising share plans is added to the average number of shares used for the calculation of diluted earnings per share.

